These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 331919)
21. The clinical efficacy of Cyclospasmol: a review of the literature. Blakemore CB Br J Clin Pract Suppl; 1984; 34():3-9. PubMed ID: 6430319 [No Abstract] [Full Text] [Related]
22. Clinical efficacy and central mechanisms of cyclandelate in migraine: a double-blind placebo-controlled study. Siniatchkin M; Gerber WD; Vein A Funct Neurol; 1998; 13(1):47-56. PubMed ID: 9584874 [TBL] [Abstract][Full Text] [Related]
23. [Controlled clinical study of Novodil in the treatment of senile macular lesions]. Delafoulhouje C; Dalens H; Solé P Bull Soc Ophtalmol Fr; 1985 Oct; 85(10):1065-7. PubMed ID: 3915881 [No Abstract] [Full Text] [Related]
24. [Efficacy of an etofylline-cyclandelate combination in age-dependent cerebrovascular insufficiency]. Foltyn P; Lücker PW; Schnitker J Arzneimittelforschung; 1982; 32(10):1322-8. PubMed ID: 6891235 [TBL] [Abstract][Full Text] [Related]
25. Cyclandelate in diabetic radiculoneuropathy. van der Drift JH Ann Neurol; 1980 Apr; 7(4):388. PubMed ID: 7377764 [No Abstract] [Full Text] [Related]
26. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study. Gerber WD; Schellenberg R; Thom M; Haufe C; Bölsche F; Wedekind W; Niederberger U; Soyka D Funct Neurol; 1995; 10(1):27-35. PubMed ID: 7649498 [TBL] [Abstract][Full Text] [Related]
27. Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice. de Halleux F Drugs; 1987; 33 Suppl 2():114-9. PubMed ID: 3622305 [TBL] [Abstract][Full Text] [Related]
28. Chronic cerebrovascular disorders: a clinical study with cyclandelate. Bassi S; Albizzati MG; Sbacchi M; Frattola L Br J Clin Pract; 1984 Oct; 38(10):344-9. PubMed ID: 6498057 [No Abstract] [Full Text] [Related]
29. The anti-hypoxaemic effect of cyclandelate in man measured in human volunteers using computer-assisted oculodynamic methodology. Schaffler K Br J Clin Pract Suppl; 1984; 34():51-7. PubMed ID: 6430324 [No Abstract] [Full Text] [Related]
30. Cyclandelate in the management of tinnitus: a randomized, placebo-controlled study. Hester TO; Theilman G; Green W; Jones RO Otolaryngol Head Neck Surg; 1998 Mar; 118(3 Pt 1):329-32. PubMed ID: 9527112 [TBL] [Abstract][Full Text] [Related]
31. Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patients. Memin Y Drugs; 1987; 33 Suppl 2():120-4. PubMed ID: 3497796 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of atherosclerosis in the rabbit by cyclandelate. Middleton A; Edwards E; White DA; Middleton B Br J Clin Pract Suppl; 1984; 34():39-42. PubMed ID: 6430322 [No Abstract] [Full Text] [Related]
34. Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders. Albizzati MG; Bassi S; Sbacchi M; Frattola L Br J Clin Pract Suppl; 1984; 34():69-73. PubMed ID: 6430327 [No Abstract] [Full Text] [Related]
35. Effect of cyclospasmol on early diabetic retinopathy. Mota MC; Leite E; Ruas MA; Verjans HL; Blakemore CB; Cunha-Vaz JG Int Ophthalmol; 1987 Feb; 10(1):3-9. PubMed ID: 3549595 [TBL] [Abstract][Full Text] [Related]
36. A pilot study to evaluate the effect of acute and long-term administration of cyclandelate on the vigilance of subjects submitted to hypoxic conditions. Preliminary report. Schaffler K; Hörmann E; Arnold H Arzneimittelforschung; 1981; 31(6):1032-5. PubMed ID: 7196236 [TBL] [Abstract][Full Text] [Related]
37. Treatment of the cerebral manifestations of arteriosclerosis with cyclandelate. Young J; Hall P; Blakemore C Br J Psychiatry; 1974 Feb; 124(579):177-80. PubMed ID: 4596673 [No Abstract] [Full Text] [Related]
38. Cyclandelate in the prophylaxis of migraine: a placebo-controlled study. Diener HC; Krupp P; Schmitt T; Steitz G; Milde K; Freytag S Cephalalgia; 2001 Feb; 21(1):66-70. PubMed ID: 11298666 [TBL] [Abstract][Full Text] [Related]
39. Folic acid with or without vitamin B12 for cognition and dementia. Malouf M; Grimley EJ; Areosa SA Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018 [TBL] [Abstract][Full Text] [Related]
40. Calcium modulation and clinical effect. Profile of cyclandelate. Timmerman H Drugs; 1987; 33 Suppl 2():1-4. PubMed ID: 3622303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]